SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
Relative Value
The Relative Value of one
SMSPHARMA
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 380.2 INR,
SMS Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SMSPHARMA Competitors Multiples
SMS Pharmaceuticals Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
|
35.6B INR | 4 | 39.7 | 21 | 26.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.8 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.1 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.5B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.9B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9.5 | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91B GBP | 2.8 | 15.8 | 7.9 | 11.3 |